4//SEC Filing
Kaye Randall 4
Accession 0000950170-24-128962
CIK 0001832168other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 8:13 PM ET
Size
7.2 KB
Accession
0000950170-24-128962
Insider Transaction Report
Form 4
Kaye Randall
CMO
Transactions
- Exercise/Conversion
Common Stock
2024-11-19$6.00/sh+30,554$183,324→ 48,474 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-19−30,554→ 175,946 totalExercise: $6.00Exp: 2032-03-20→ Common Stock (30,554 underlying)
Footnotes (3)
- [F1]Represents a cash exercise of vested stock options without a subsequent sale of the underlying shares of common stock.
- [F2]Includes the 17,920 restricted stock units (RSUs) that were granted on February 8, 2024, and reported in a Form 4 filed on February 9, 2024. The RSUs will vest in four equal annual installments commencing on February 8, 2025, and the shares underlying the RSUs will be issued upon vesting and release of the RSUs.
- [F3]1/4th of the shares subject to the stock option vest on March 21, 2023, and the remaining shares vest in 36 equal monthly installments thereafter.
Documents
Issuer
Longboard Pharmaceuticals, Inc.
CIK 0001832168
Entity typeother
Related Parties
1- filerCIK 0001350416
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 8:13 PM ET
- Size
- 7.2 KB